Kolexia
Guihot Amelie
Pneumologie
Hôpital Pitie Salpetriere
Paris, France
79 Activités
216 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Tumeurs du poumon Carcinome pulmonaire non à petites cellules Syndrome de détresse respiratoire de l'adulte Tuberculose Sarcome de Kaposi Grippe humaine Virémie

Industries

MSD
2 collaboration(s)
Dernière en 2021
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

CAR-T cell therapy for central nervous system lymphomas: blood and cerebrospinal fluid biology, and outcomes.
Haematologica   22 juin 2023
Identification of natural killer markers associated with fatal outcome in COVID-19 patients.
Frontiers in cellular and infection microbiology   05 juin 2023
T-SPOT. performed in lymphnodal tissue for the diagnosis of lymphadenitic TB.
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease   14 mars 2023
Anti-PD-1 immune-related adverse events are associated with high therapeutic antibody fixation on T cells.
Frontiers in immunology   20 décembre 2022
EBV Dictates Lower Tumor Neoepitopes Scores and Intra-Tumoral Repertoire Diversity in NHL from Immuno-Compromized Patients
Annual Meeting Abstracts 2022   15 novembre 2022
Comparison between enzyme-linked immunospot assay and intracellular cytokine flow cytometry assays for the evaluation of T cell response to SARS-CoV-2 after symptomatic COVID-19.
Immunity, inflammation and disease   29 septembre 2022
Memory CD4+ T-Cell Lymphocytic Angiopathy in Fatal Forms of COVID-19 Pulmonary Infection.
Frontiers in immunology   22 avril 2022
Progressive multifocal leukoencephalopathy after first-line radiotherapy and temozolomide for glioblastoma.
Neuro-oncology   22 mars 2022
Impact of Anti PD-1 Immunotherapy on HIV Reservoir and Anti-Viral Immune Responses in People Living with HIV and Cancer.
Cells   17 mars 2022
Evolution of anti-SARS-CoV-2 immune response in a cohort of French healthcare workers followed for 7 months.
Infectious diseases now   19 janvier 2022